CASE STUDY: EARLY-ONSET CATARACT IN A 42-YEAR-OLD FEMALE WITH SICKLE CELL DISEASE
DOI:
https://doi.org/10.62019/mrbcdc62Keywords:
Sickle Cell Disease, Early-Onset Cataract, Phacoemulsification, HbSS Genotype, Oxidative StressAbstract
The sickle cell disease (SCD) refers to a genetic hemoglobin disease with systemic and ocular complications. The proliferative retinopathy is famous but the cataract formation in SCD is underresearched. The present case report includes a history of a 42-year-old female with homozygous SCD (HbSS genotype) who has reported a four-month history of bilateral progressive loss of visual function. The visual acuity was also reduced to 6/60 in either eye. The slit-lamp biopsy revealed that she had nuclear and cortical cataracts of the advanced type without any trauma, diabetes, or corticosteroids. The existence of intact vitreoretinal structures was ensured by the B-scan ultrasonography. The perioperative optimization was conducted per the hydration, oxygenation, and analgesia after a hematology consultation, and transfusion was not administered. The surgery was performed on intraocular lens implantation under topical anesthesia in sequential phacoemulsification. Recovery was not eventful, and bilateral best-corrected visual acuity of 6/9 was achieved after one month and it is sufficient to have functional independence. The case states that the pathophysiological role of chronic hypoxia, oxidative stress and frequent vaso-occlusive crisis in the acceleration of cataractogenesis in SCD patients decades before the normal population is a factor. Early screening of SCD by ophthalmologists and multidisciplinary perioperative planning and early surgical intervention are the keys to preventing avoidable visual disability and improving the quality of life experienced by the affected patients.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sailesh Kapair MD (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the Journal of Medical & Health Sciences Review (JMHSR) remain the copyright of their respective authors. JMHSR publishes its content under the Creative Commons Attribution‑NonCommercial 4.0 International License (CC BY‑NC 4.0), which allows readers to freely share, copy, adapt, and build upon the work for non‑commercial purposes, provided proper credit is given to both the authors and the journal.



